The place of varenicline in smoking cessation treatment.
Aveyard
Paul
P
D001552:Benzazepines / Q000191:economics / Q000627:therapeutic use*; D016642:Bupropion / Q000191:economics / Q000627:therapeutic use; D018678:Cholinergic Agents / Q000191:economics / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D018765:Dopamine Uptake Inhibitors / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D006801:Humans; D011810:Quinoxalines / Q000191:economics / Q000627:therapeutic use*; D012907:Smoking / Q000191:economics; D016540:Smoking Cessation / Q000191:economics / Q000379:methods*; D000074606:Smoking Prevention; D000068580:Varenicline
D001552:Benzazepines; D018678:Cholinergic Agents; D018765:Dopamine Uptake Inhibitors; D011810:Quinoxalines; D016642:Bupropion; D000068580:Varenicline